Restatement of Consolidated Financial Statements (Tables)

12 Months Ended

Dec. 31, 2021

Condensed Financial Information Disclosure [Abstract]

Schedule of consolidated balance sheet

	December 31, 2021
	As Previously Reported			Adjustments			As Restated
Conversion Feature derivative liability	$	-		$	8,355		$	8,355
Total current liabilities		29,526			8,355			37,881
Accumulated deficit		(40,910	)		(8,355	)		(49,265	)
Total stockholders’ deficit		(4,753	)		(8,355	)		(13,108	)

Schedule of consolidated statements of operations

	Year ended December 31, 2021
	As Previously Reported			Adjustments			As Restated
Other Income (Expense)
Loss contingency on debt default	$	(6,594	)	$	(1,227	)	$	(7,821	)
Revaluation of conversion feature derivative liability		-			(6,278	)		(6,278	)
Interest Expense		(2,991	)		(850	)		(3,841	)
Net Loss – continuing operations		(46,011	)		(8,355	)		(54,366	)
Net Loss per share - basic and diluted - continuing operations	$	(0.33	)		(0.06	)		(0.39	)
Weighted Average Shares Outstanding - basic and diluted		139,061,084			-			139,061,084

Schedule of consolidated statement of cash flows

	Year ended December 31, 2021
	As Previously Reported			Adjustments			As Restated
Net loss from continuing operations	$	(46,011	)	$	(8,355	)	$	(54,366	)
Changes in adjustment to reconcile net loss to net cash used in operating activities
Loss contingency on debt default		6,594			1,227			7,821
Change in fair value of derivative liability		-			6,278			6,278
Amortization of debt discount and debt issuance costs		1,323			850			2,173
Net cash used in operating activities	$	(8,473	)		-			(8,473	)